Genocea Biosciences (GNCA) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Genocea Provides Fourth Quarter 2019 Corporate Update
February 13, 2020 7:01 AM ESTATLASTM identifies Inhibigenstm that can undermine immunotherapy
Dosed first patient in Part B of GEN-009 neoantigen vaccine Phase 1/2a trial
Progressed GEN-011 neoantigen cell therapy - IND filing expected in Q2 2020
Appointed Dr. Gisela Schwab to Genoceas Board of Directors
Conference call today at 8:30 a.m. EDT
CAMBRIDGE, Mass., Feb. 13, 2020 (GLOBE NEWSWIRE) --... More
